About this trial
Anemia remains a major public health concern and is commonly diagnosed through hemoglobin measurement using capillary or venous blood samples. Although laboratory-based and point-of-care testing methods are widely used, they require blood collection, trained personnel, and may cause discomfort to participants. Non-invasive spectrophotometric technology has emerged as a potential alternative for rapid hemoglobin assessment without blood sampling.
This study aims to evaluate the validity and diagnostic performance of a non-invasive hemoglobin using optical method compared with capillary point-of-care testing (POCT) and venous blood hemoglobin measured using an automated hematology analyzer as the reference standard. A total of 150 adults from Kelurahan Kota Bambu, Jakarta, will undergo non-invasive hemoglobin measurement, capillary blood testing, and venous blood testing during a single study visit.
The study will assess agreement between methods, diagnostic accuracy for anemia detection, and factors that may influence measurement performance. Findings from this study are expected to support the development of convenient, community-based anemia screening strategies and provide evidence for future implementation of non-invasive hemoglobin assessment technologies.
Eligibility criteria
Qualifiers
Adults aged 18 years and older.
Residents or community members participating in community health screening activities in Kelurahan Kota Bambu, Jakarta.
Willing to undergo non-invasive hemoglobin measurement.
Willing to undergo capillary blood hemoglobin testing using point-of-care testing (POCT).
Disqualifiers
Active bleeding at the time of examination.
Severe acute illness requiring urgent medical attention.
Refusal to undergo finger-prick or venous blood sampling.
History of severe anxiety, syncope, or adverse reactions related to blood collection procedures.
Trial design
Treatments tested in this trial
- Not listed